
Human CAMEL 1-11, MLMAQEALAFL
Description
About Human CAMEL 1-11, MLMAQEALAFL
The Human CTL-recognized antigen on melanoma (CAMEL) Peptide (IEDB: 1075514) is a high quality epitope peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxicity or proliferation assays. The CTL-recognized antigen on melanoma (CAMEL) Peptide, H-MLMAQEALAFL-OH (Uniprot: O95987 aa: 1-11) from JPT is produced under strict quality control and quality management.
Human CAMEL 1-11, MLMAQEALAFL - Specifications
- Peptide sequence: H-MLMAQEALAFL-OH
- Amount: 10 mg (10 x 1 mg)
- Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
- Counterion: TFA
- Delivery Format: Freeze-dried in glass vial
- Application(s): T-cell Immunity
- Condition(s)/Topic(s): Lung cancer, Melanoma
- Standard Delivery Time: approx. 3 weeks
JPT’s Antigen Peptides
Find your antigen peptide and select the connected PepMix™ Peptide Pool for efficient immune monitoring, mapping of T cell epitopes or development of immunotherapy and vaccines. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.
Not found what you are looking for? Request a Quote for you custom antigen peptide!
Benefits of JPT’s Antigen Peptides
- All peptides are made in Germany
- Bulk orders or custom peptide snythesis upon request
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies
- Order the connected PepMix™ Peptide Pool with your peptide!
References
References for Human CAMEL 1-11, MLMAQEALAFL
References:
Read References with JPT’s Antigen Peptides
Human CAMEL 1-11, MLMAQEALAFL has been described in:
Landscape mapping of shared antigenic epitopes and their cognate TCRs of tumor-infiltrating T lymphocytes in melanoma., Elife, 2020 (PMID: 32314731)
A New Plasmacytoid Dendritic Cell-Based Vaccine in Combination with Anti-PD-1 Expands the Tumor-Specific CD8+ T Cells of Lung Cancer Patients., Int J Mol Sci, 2023 (PMID: 36768214)
Documentation
Documentation for Human CAMEL 1-11, MLMAQEALAFL
Properties
Properties of Human CAMEL 1-11, MLMAQEALAFL
Properties | Values |
---|---|
Application: | T-cell immunity |
Category: | Antigen Peptides |
Condition / Topic: | Lung cancer, Melanoma |
Layout: | Freeze-dried in glass vial |
Organism: | Human |
Protein Name: | CTL-recognized antigen on melanoma (CAMEL) |
Purity: | Trial Grade: each peptide purified to > 90% (HPLC/MS) |
Quantification: | No, Yes |
Further Information to Human CAMEL 1-11, MLMAQEALAFL
Information | Values |
---|---|
Sequence: | H-MLMAQEALAFL-OH |
Specifications: | 11mer peptide as TFA salt |